Søgeresultater - Saša Masleša-Galić
- Showing 1 - 5 results of 5
-
1
-
2
-
3
A Replication-Limited Recombinant <i>Mycobacterium bovis</i> BCG Vaccine against Tuberculosis Designed for Human Immunodeficiency Virus-Positive Persons Is Safer and More Efficacio... af Michael V. Tullius, Günter Harth, Saša Masleša-Galić, Barbara Jane Dillon, Marcus A. Horwitz
Udgivet 2008Artigo -
4
Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters af Qingmei Jia, Helle Bielefeldt‐Ohmann, Rachel M. Maison, Saša Masleša-Galić, Sarah K. Cooper, Richard A. Bowen, Marcus A. Horwitz
Udgivet 2021Artigo -
5
Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time af Bai‐Yu Lee, Daniel L. Clemens, Aleidy Silva, Barbara Jane Dillon, Saša Masleša-Galić, Susana Nava, Xianting Ding, Chih‐Ming Ho, Marcus A. Horwitz
Udgivet 2017Artigo
Søgeredskaber:
Relaterede emner
Biology
Medicine
Pathology
Biochemistry
Gene
Microbiology
Mycobacterium tuberculosis
Tuberculosis
Immunology
Virology
Attenuated vaccine
BCG vaccine
Molecular biology
Mycobacterium bovis
Recombinant DNA
Tuberculosis vaccines
Vaccination
Virulence
Amino acid
Bacilli
Bacteria
Bedaquiline
Biotechnology
Coronavirus disease 2019 (COVID-19)
Disease
Drug
Drug resistance
ESAT-6
Enzyme
Genetics